Global Glycomics/Glycobiology Market Projected to Reach USD 2,711.89 Million by 2026

12-Mar-2020 | Facts and Factors

Findings from Facts and Factors report “Glycomics/Glycobiology Market by Product (enzymes, kits, reagents, and instruments), application (Drug Discovery & Development, Diagnostics and Others), End-user (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies and CROs): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global Glycomics/Glycobiology market in 2019 was approximately USD 1,040.31 million. The market is expected to grow at a CAGR of 14.71% and is anticipated to reach around USD 2,711.89 million by 2026.

Glycobiology is the analysis of carbohydrate formation, function and physiology also called glycans. Each living organism produces glycans. Glycobiology is an increasing area of interest in biomedicine, biotechnology, and fundamental research. Within eukaryotic cells, several proteins are changed post-translationally. Attachment of glycans, or "glycosylation," is one of the most important modifications to cell viability. Glycosylation happens in two forms: O-linked (glycan attached to serine or threonine) and N-linked (glycan attached to asparagine).

Browse the full “Glycomics/Glycobiology Market by Product (enzymes, kits, reagents, and instruments), application (Drug Discovery & Development, Diagnostics and Others), End-user (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies and CROs): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" https://www.fnfresearch.com/glycomicsglycobiology-market-by-product-enzymes-kits-reagents-and-702

Increasing drug discovery and production leads biotech companies to increase their R&D spending. Consequently, glycomics research techniques are increasingly required to perform a comprehensive study of glycomes. Increasing the number of government initiatives to raise funding for R&D also helped increase the need for glycomic techniques. Such financing initiatives are expected to improve interest in glycomics testing techniques in the near future. In fact, core organizations are undertaking robust R&D initiatives to create new and technologically advanced goods.

The market for Glycomics/Glycobiologyis divided into product, application, end-user, and region. The product type segment is classified into enzymes, kits, reagents, and instruments. Enzymes are projected to be the fastest-growing segment on the global Glycomics / Glycobiology market due to its wide range of testing & diagnostic applications and the frequent purchasing of these drugs. The industry is categorized according to application into Drug Discovery & Growth, Diagnostics, and Others. Drug discovery & development produced the largest share of revenue in 2018 and focused on developing new drugs due to the high demand for customized products.

Region-wise the market is segmented into the regions that comprise the current and forecast market demand for the Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa with its further split into major countries. North America led the overall glycomics/glycobiology industry in 2019 and is expected to continue to lead over the forecast period. A growing number of research labs and pharmaceutical and biotechnology firms are involved in North America's key driver of the regional market.

Report Scope

Some of the players included in Glycomics/Glycobiology market

Agilent Technologies, Bruker, Danaher, Merck KGaA, New England Biolabs, ProZyme, Shimadzu Corporation, Takara Bio, Inc., ThermoFisher Scientific, Inc., and Waters Corporation amongst others.

This report segments the Glycomics/Glycobiology Market as follows:

By Product Segment Analysis

• Enzymes
  • Glycosidases
  • Neuraminidases
  • Glycosyltransferases
  • Sialyltransferases
  • Others
• Kits
  • Glycan Labeling Kits
  • Glycan Purification Kits
  • Glycan Release Kits
  • Others
• Reagents
  • Glycoproteins
  • Monosaccharides
  • Oligosaccharides
  • Others
• Instruments
  • Mass Spectrometers
  • HPLC
  • MALDI-TOF
  • Array Systems
  • Others

By Application Segment Analysis

• Drug Discovery & Development
• Diagnostics
• Others

By End-user Segment Analysis

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• CROs

By Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:

Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com